Targeting apoptosis in cancer therapy

BA Carneiro, WS El-Deiry - Nature reviews Clinical oncology, 2020 - nature.com
For over three decades, a mainstay and goal of clinical oncology has been the development
of therapies promoting the effective elimination of cancer cells by apoptosis. This …

Mechanism of interaction between autophagy and apoptosis in cancer

S Das, N Shukla, SS Singh, S Kushwaha… - Apoptosis, 2021 - Springer
The mechanisms of two programmed cell death pathways, autophagy, and apoptosis, are
extensively focused areas of research in the context of cancer. Both the catabolic pathways …

Targeting apoptosis in cancer

P Singh, B Lim - Current oncology reports, 2022 - Springer
Abstract Purpose of Review Apoptosis is a major mechanism of cancer cell death. Thus,
evasion of apoptosis results in therapy resistance. Here, we review apoptosis modulators in …

[HTML][HTML] Targeting apoptotic caspases in cancer

A Boice, L Bouchier-Hayes - … et Biophysica Acta (BBA)-Molecular Cell …, 2020 - Elsevier
Members of the caspase family of proteases play essential roles in the initiation and
execution of apoptosis. These caspases are divided into two groups: the initiator caspases …

Ubiquitin ligases in oncogenic transformation and cancer therapy

D Senft, J Qi, ZA Ronai - Nature Reviews Cancer, 2018 - nature.com
The cellular response to external stress signals and DNA damage depends on the activity of
ubiquitin ligases (E3s), which regulate numerous cellular processes, including homeostasis …

Small-molecule inhibitors of protein-protein interactions: progressing toward the reality

MR Arkin, Y Tang, JA Wells - Chemistry & biology, 2014 - cell.com
The past 20 years have seen many advances in our understanding of protein-protein
interactions (PPIs) and how to target them with small-molecule therapeutics. In 2004, we …

Integrated drug profiling and CRISPR screening identify essential pathways for CAR T-cell cytotoxicity

O Dufva, J Koski, P Maliniemi, A Ianevski… - Blood, The Journal …, 2020 - ashpublications.org
Chimeric antigen receptor (CAR) T-cell therapy has proven effective in relapsed and
refractory B-cell malignancies, but resistance and relapses still occur. Better understanding …

The roles of E3 ubiquitin ligases in cancer progression and targeted therapy

C Sampson, Q Wang, W Otkur, H Zhao… - Clinical and …, 2023 - Wiley Online Library
Ubiquitination is one of the most important post‐translational modifications which plays a
significant role in conserving the homeostasis of cellular proteins. In the ubiquitination …

A review of the current impact of inhibitors of apoptosis proteins and their repression in cancer

P Cetraro, J Plaza-Diaz, A MacKenzie… - Cancers, 2022 - mdpi.com
Simple Summary The Inhibitor of Apoptosis (IAP) family of proteins has emerged as a
potential pharmacological target in cancer. Abnormal expression of IAPs can lead to …

[HTML][HTML] Macrophage and neutrophil death programs differentially confer resistance to tuberculosis

MD Stutz, CC Allison, S Ojaimi, SP Preston… - Immunity, 2021 - cell.com
Apoptosis can potently defend against intracellular pathogens by directly killing microbes
and eliminating their replicative niche. However, the reported ability of Mycobacterium …